HUP0101258A2 - Helyettesített bisz-indolil-maleimidek, sejtburjánzás gátlására történő felhasználásra - Google Patents

Helyettesített bisz-indolil-maleimidek, sejtburjánzás gátlására történő felhasználásra

Info

Publication number
HUP0101258A2
HUP0101258A2 HU0101258A HUP0101258A HUP0101258A2 HU P0101258 A2 HUP0101258 A2 HU P0101258A2 HU 0101258 A HU0101258 A HU 0101258A HU P0101258 A HUP0101258 A HU P0101258A HU P0101258 A2 HUP0101258 A2 HU P0101258A2
Authority
HU
Hungary
Prior art keywords
substituted
bisindolymaleimides
inhibition
cell proliferation
methyl group
Prior art date
Application number
HU0101258A
Other languages
English (en)
Inventor
Urvashi Hooda Dhingra
Donna Mary Huryn
June Ke
Giuseppe Federico Weber
Original Assignee
F. Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag. filed Critical F. Hoffmann-La Roche Ag.
Publication of HUP0101258A2 publication Critical patent/HUP0101258A2/hu
Publication of HUP0101258A3 publication Critical patent/HUP0101258A3/hu
Publication of HU228831B1 publication Critical patent/HU228831B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Az (I) általános képletű helyettesített pirrolok (mely képletben Rljelentése hidrogénatom és R2 jelentése metilcsoport; vagy Rl jelentésemetilcsoport és R2 jelentése hidrogénatom; vagy Rl jelentése hidroxi-metil-csoport és R2 jelentése metilcsoport) és gyógyászatilag alkalmaselőgyógyszereik (prodrug) és gyógyászatilag alkalmas sóik a rákkezelésénél felhasználható burjánzásgátló hatóanyagok. Ó
HU0101258A 1998-03-17 1999-03-10 Substituted bisindolylmaleimides, their use and pharmaceutical compositions containing them HU228831B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17
PCT/EP1999/001534 WO1999047518A1 (en) 1998-03-17 1999-03-10 Substituted bisindolymaleimides for the inhibition of cell proliferation

Publications (3)

Publication Number Publication Date
HUP0101258A2 true HUP0101258A2 (hu) 2001-10-28
HUP0101258A3 HUP0101258A3 (en) 2002-08-28
HU228831B1 HU228831B1 (en) 2013-05-28

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101258A HU228831B1 (en) 1998-03-17 1999-03-10 Substituted bisindolylmaleimides, their use and pharmaceutical compositions containing them

Country Status (34)

Country Link
US (1) US6048887A (hu)
EP (1) EP1064279B1 (hu)
JP (2) JP5026633B2 (hu)
KR (1) KR100659411B1 (hu)
CN (1) CN1127500C (hu)
AR (1) AR018162A1 (hu)
AT (1) ATE243693T1 (hu)
AU (1) AU755673B2 (hu)
BR (1) BR9908882A (hu)
CA (1) CA2322689C (hu)
CO (1) CO5070675A1 (hu)
CZ (1) CZ299068B6 (hu)
DE (1) DE69909068T2 (hu)
DK (1) DK1064279T3 (hu)
ES (1) ES2203111T3 (hu)
HK (1) HK1036452A1 (hu)
HR (1) HRP20000585B1 (hu)
HU (1) HU228831B1 (hu)
ID (1) ID26353A (hu)
IL (1) IL138247A (hu)
MA (1) MA26613A1 (hu)
MY (1) MY121046A (hu)
NO (1) NO320306B1 (hu)
NZ (1) NZ506476A (hu)
PE (1) PE20000340A1 (hu)
PL (1) PL195323B1 (hu)
PT (1) PT1064279E (hu)
RS (1) RS49965B (hu)
RU (1) RU2208612C2 (hu)
SA (1) SA99191295B1 (hu)
TR (1) TR200002580T2 (hu)
TW (1) TW539676B (hu)
WO (1) WO1999047518A1 (hu)
ZA (1) ZA992072B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243693T1 (de) * 1998-03-17 2003-07-15 Hoffmann La Roche Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
MXPA02003667A (es) * 1999-10-12 2002-08-30 Hoffmann La Roche Pirroles sustituidos como agentes antiproliferativos para tratamiento del cancer.
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
EP1449529B1 (en) * 1993-12-23 2010-01-27 Eli Lilly And Company Protein Kinase C Inhibitors
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
ATE243693T1 (de) * 1998-03-17 2003-07-15 Hoffmann La Roche Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Also Published As

Publication number Publication date
PL195323B1 (pl) 2007-09-28
SA99191295B1 (ar) 2006-04-26
ZA992072B (en) 1999-09-22
CN1293671A (zh) 2001-05-02
NO20004579L (no) 2000-09-14
MY121046A (en) 2005-12-30
RS49965B (sr) 2008-09-29
PE20000340A1 (es) 2000-05-13
CA2322689A1 (en) 1999-09-23
IL138247A (en) 2005-08-31
PL342964A1 (en) 2001-07-16
AR018162A1 (es) 2001-10-31
CN1127500C (zh) 2003-11-12
CO5070675A1 (es) 2001-08-28
WO1999047518A1 (en) 1999-09-23
KR20010041995A (ko) 2001-05-25
AU3409999A (en) 1999-10-11
HRP20000585B1 (en) 2009-02-28
ATE243693T1 (de) 2003-07-15
HRP20000585A2 (en) 2001-08-31
DK1064279T3 (da) 2003-10-06
CZ20003384A3 (cs) 2000-12-13
JP5026633B2 (ja) 2012-09-12
NO320306B1 (no) 2005-11-21
JP2002506864A (ja) 2002-03-05
YU55200A (sh) 2002-11-15
HK1036452A1 (en) 2002-01-04
HUP0101258A3 (en) 2002-08-28
DE69909068D1 (de) 2003-07-31
ES2203111T3 (es) 2004-04-01
IL138247A0 (en) 2001-10-31
TW539676B (en) 2003-07-01
DE69909068T2 (de) 2004-05-06
AU755673B2 (en) 2002-12-19
JP2010222366A (ja) 2010-10-07
EP1064279A1 (en) 2001-01-03
CA2322689C (en) 2008-11-25
KR100659411B1 (ko) 2006-12-18
CZ299068B6 (cs) 2008-04-16
MA26613A1 (fr) 2004-12-20
ID26353A (id) 2000-12-14
US6048887A (en) 2000-04-11
NZ506476A (en) 2003-12-19
TR200002580T2 (tr) 2000-11-21
EP1064279B1 (en) 2003-06-25
HU228831B1 (en) 2013-05-28
PT1064279E (pt) 2003-10-31
NO20004579D0 (no) 2000-09-14
RU2208612C2 (ru) 2003-07-20
BR9908882A (pt) 2000-11-21

Similar Documents

Publication Publication Date Title
HUP0101258A2 (hu) Helyettesített bisz-indolil-maleimidek, sejtburjánzás gátlására történő felhasználásra
BG106586A (en) Pyrazolopyramidines as therapeutic agents
HUP0301120A2 (hu) Szubsztituált fenilamino-kinazolin-származékok, alkalmazásuk rendellenes sejtnövekedés kezelésére és azokat tartalmazó gyógyszerkészítmények
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
NO943877D0 (no) Hemming av proliferasjon av glatte muskelceller og restenose
YU37903A (sh) POSTUPCI LEČENJA STANJA POVEZANIH SA p38 KINAZOM I JEDINJENJA PIROLOTRIAZINA KOJA SE KORISTE KAO INHIBITORI KINAZE
NO996578L (no) Urokinase-inhibitorer
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
HUP0500138A2 (hu) Heterogyűrűvel helyettesített 2-(4-fenoxi)pirimidinszármazékok és ezekkel rokon vegyületek mint nátriumcsatorna-gátlók idegsejt-károsodás és neurodegeneratív állapotok kezelésére
TR199800815A2 (en) S�lfonilaminokarbonasitler.
TR199900157T2 (xx) H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
PT1173439E (pt) Haloalcoxi imidazonaftiridinas
MXPA02009551A (es) Profarmacos de derivados de imidazopiridina.
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
DE69910799D1 (de) Als inhibitoren der aicarftnützliche verbindungen
PA8466101A1 (es) Agentes terapeuticos
AR026350A1 (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa vii
MY136181A (en) Farnesyltransferase inhibitors
ATE273985T1 (de) Ruthenium (ii) verbindungen in der krebsbehandlung
TR200102576T2 (tr) Kanser tedavisinde radyoaktif sisplatin
IL139144A0 (en) Mycobacterial inhibitors